Additionally, SGLT2 inhibitors promote the excretion of sodium from the kidneys, which reduces water in the body, which in turn lowers the pressure on the heart, helping to alleviate symptoms in patients with heart failure [88]. The gene discussed is SLC5A2; the disease is heart failure.